BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 25783847)

  • 1. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss.
    Tsai HT; Hsueh N; Huang CM; Lin HC
    Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss.
    Günel C; Başal Y; Toka A; Eryılmaz A; Kurt Ömürlü I
    Auris Nasus Larynx; 2015 Aug; 42(4):284-7. PubMed ID: 25725564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.
    Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW
    Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
    Baysal E; Tunç O; Baglam T; Durucu C; Oz A; Karatas ZA; Polat M; Celenk F; Mumbuc S; Kanlikama M
    J Craniofac Surg; 2013 Mar; 24(2):432-4. PubMed ID: 23524709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.
    Lee JB; Choi SJ; Park K; Park HY; Choo OS; Choung YH
    Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):833-9. PubMed ID: 21221620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
    Yoo MH; Lim WS; Park JH; Kwon JK; Lee TH; An YH; Kim YJ; Kim JY; Lim HW; Park HJ
    Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Concurrent or Sequential Intravenous and Intratympanic Steroid for Idiopathic Sudden Sensorineural Hearing Loss.
    Chu CH; Chiou SR; Wang MC; Shiao AS; Tu TY; Lin LY; Huang CY; Liao WH
    Audiol Neurootol; 2018; 23(5):277-284. PubMed ID: 30537751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
    Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
    Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.
    Lee JB; Choi SJ
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy.
    Suzuki H; Hashida K; Nguyen KH; Hohchi N; Katoh A; Koizumi H; Ohbuchi T
    Laryngoscope; 2012 May; 122(5):1154-7. PubMed ID: 22447636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of idiopathic sudden sensorineural hearing loss with intratympanic steroid injection.
    Khaimook W; Jantarapattana K
    J Med Assoc Thai; 2011 Dec; 94(12):1495-9. PubMed ID: 22295738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and prognosis associated with intra-tympanic steroid injection to treat sudden sensorineural hearing impairment.
    Hu CY; Lien KH; Chen SL; Zhang BY; Chan KC
    Am J Otolaryngol; 2022; 43(1):103221. PubMed ID: 34536925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
    Sun RX; Zhao Y; Liu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066
    [No Abstract]   [Full Text] [Related]  

  • 18. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
    Zhong SX; Zuo WQ; Zhang BY; Qian Y; Lei Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 53(11):806-810. PubMed ID: 30453397
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
    Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial.
    Yang W; Li X; Zhong J; Mei X; Liu H; Yang L; Lu L; Hu H
    Trials; 2020 Feb; 21(1):135. PubMed ID: 32014060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.